AADI BIOSCIENCE, INC.

(AADI)
  Report
Real-time Estimate Cboe BZX  -  05/24 02:08:37 pm EDT
14.41 USD   -2.14%
05/18Aadi Bioscience to Present at the H.C. Wainwright Global Investment Conference
AQ
05/12AADI BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
05/12Earnings Flash (AADI) AADI BIOSCIENCE Reports Q1 Revenue $2.3M
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Flat Ahead of Tuesday's Opening Bell

11/23/2021 | 09:03am EDT


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
AADI BIOSCIENCE, INC. -1.97% 14.43 Delayed Quote.-39.05%
AGILENT TECHNOLOGIES, INC. -1.23% 124.43 Delayed Quote.-21.62%
ARROWHEAD PHARMACEUTICALS, INC. -5.28% 34.195 Delayed Quote.-45.63%
GLAXOSMITHKLINE PLC 0.00% 1782 Delayed Quote.10.92%
All news about AADI BIOSCIENCE, INC.
05/18Aadi Bioscience to Present at the H.C. Wainwright Global Investment Conference
AQ
05/12AADI BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and ..
AQ
05/12Earnings Flash (AADI) AADI BIOSCIENCE Reports Q1 Revenue $2.3M
MT
05/12TRANSCRIPT : Aadi Bioscience, Inc., Q1 2022 Earnings Call, May 12, 2022
CI
05/12Aadi Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 20..
CI
05/12Earnings Flash (AADI) AADI BIOSCIENCE Reports Q1 Revenue $2.3M, vs. Street Est of $0.41..
MT
05/12Aadi Bioscience Reports First Quarter 2022 Financial Results and Provides a Corporate U..
AQ
05/09Aadi Bioscience Announces Collaborations with Next Generation Sequencing Leaders
AQ
05/09Aadi Bioscience Announces Collaborations with Next Generation Sequencing Leaders
CI
05/05Aadi Bioscience Announces Unique Permanent J-code Issued for FYARRO from Centers for Me..
AQ
More news
Analyst Recommendations on AADI BIOSCIENCE, INC.
More recommendations
Financials (USD)
Sales 2022 14,4 M - -
Net income 2022 -60,5 M - -
Net Debt 2022 - - -
P/E ratio 2022 -5,16x
Yield 2022 -
Capitalization 308 M 308 M -
Capi. / Sales 2022 21,4x
Capi. / Sales 2023 19,6x
Nbr of Employees 54
Free-Float 86,4%
Chart AADI BIOSCIENCE, INC.
Duration : Period :
Aadi Bioscience, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 14,72 $
Average target price 43,50 $
Spread / Average Target 196%
EPS Revisions
Managers and Directors
Neil P. Desai President, CEO, Secretary & Director
Scott M. Giacobello Treasurer, Chief Financial & Accounting Officer
Caley M. Castelein Chairman
Loretta M. Itri Chief Medical Officer
Berta Grigorian Vice President-Clinical Operations
Sector and Competitors
1st jan.Capi. (M$)
AADI BIOSCIENCE, INC.-39.05%308
CSL LIMITED-6.04%93 536
SAMSUNG BIOLOGICS CO.,LTD.-10.52%46 268
WUXI BIOLOGICS (CAYMAN) INC.-39.22%30 229
BIOGEN INC.-16.89%29 203
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-28.41%22 798